ES539274A0 - Un procedimiento para la obtencion de preparados del bifanazol con elevada liberacion del producto actuvo - Google Patents

Un procedimiento para la obtencion de preparados del bifanazol con elevada liberacion del producto actuvo

Info

Publication number
ES539274A0
ES539274A0 ES539274A ES539274A ES539274A0 ES 539274 A0 ES539274 A0 ES 539274A0 ES 539274 A ES539274 A ES 539274A ES 539274 A ES539274 A ES 539274A ES 539274 A0 ES539274 A0 ES 539274A0
Authority
ES
Spain
Prior art keywords
biphanazole
procedure
high release
obtaining preparations
product acted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES539274A
Other languages
English (en)
Other versions
ES8601690A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES539274A0 publication Critical patent/ES539274A0/es
Publication of ES8601690A1 publication Critical patent/ES8601690A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES539274A 1983-03-30 1984-12-31 Un procedimiento para la obtencion de preparados del bifanazol con elevada liberacion del producto actuvo Expired ES8601690A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833311700 DE3311700A1 (de) 1983-03-30 1983-03-30 Antimykotische mittel mit hoher wirkstoff-freisetzung in form von loesung und spray

Publications (2)

Publication Number Publication Date
ES539274A0 true ES539274A0 (es) 1985-11-16
ES8601690A1 ES8601690A1 (es) 1985-11-16

Family

ID=6195161

Family Applications (3)

Application Number Title Priority Date Filing Date
ES530845A Granted ES530845A0 (es) 1983-03-30 1984-03-22 Agentes antimicoticos con elevada liberacion del producto activo
ES539275A Granted ES539275A0 (es) 1983-03-30 1984-12-31 Un procedimiento para la obtencion de derivados de bifanazol con elevada liberacion del producto activo
ES539274A Expired ES8601690A1 (es) 1983-03-30 1984-12-31 Un procedimiento para la obtencion de preparados del bifanazol con elevada liberacion del producto actuvo

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES530845A Granted ES530845A0 (es) 1983-03-30 1984-03-22 Agentes antimicoticos con elevada liberacion del producto activo
ES539275A Granted ES539275A0 (es) 1983-03-30 1984-12-31 Un procedimiento para la obtencion de derivados de bifanazol con elevada liberacion del producto activo

Country Status (18)

Country Link
JP (1) JPS59184125A (es)
KR (1) KR840008283A (es)
AU (1) AU564979B2 (es)
BE (1) BE899277A (es)
CA (1) CA1212328A (es)
CH (1) CH660304A5 (es)
DE (1) DE3311700A1 (es)
ES (3) ES530845A0 (es)
FR (1) FR2543436B1 (es)
GB (1) GB2137090B (es)
GR (1) GR81880B (es)
IL (1) IL71363A0 (es)
IT (1) IT1173762B (es)
LU (1) LU85272A1 (es)
PH (1) PH20964A (es)
PT (1) PT78312B (es)
SE (1) SE8401747L (es)
ZA (1) ZA842336B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2555555B2 (ja) * 1991-07-03 1996-11-20 武田薬品工業株式会社 抗真菌性外用製剤
US5246716A (en) * 1992-01-10 1993-09-21 W. Neudorff Gmbh Kg Fatty acid-based antifungal composition having residual activity
US6133327A (en) * 1995-12-14 2000-10-17 Taisho Pharmaceutical Co., Ltd. Aerosol preparation
EA009024B1 (ru) 2002-06-25 2007-10-26 АКРУКС ДиДиЭс ПиТиУай ЭлТиДи Фармацевтическая композиция для чрескожной доставки активного агента (варианты)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2461406C2 (de) * 1974-12-24 1984-06-14 Bayer Ag, 5090 Leverkusen Azolyl-(1)-methane und deren Salze, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
JPS6018655B2 (ja) * 1976-01-01 1985-05-11 バイエル・アクチエンゲゼルシヤフト アゾリル−(1)−メタン類及びそれらの塩
JPS5598112A (en) * 1979-01-17 1980-07-25 Sumitomo Chem Co Ltd Liquid medicine for external use
DE3019027A1 (de) * 1980-05-19 1981-11-26 Bayer Ag, 5090 Leverkusen Antimikrobielle mittel
DE3045915A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045913A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung
DE3045914A1 (de) * 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3106635A1 (de) * 1981-02-23 1982-09-09 Bayer Ag Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften

Also Published As

Publication number Publication date
GR81880B (es) 1984-12-12
JPS59184125A (ja) 1984-10-19
GB2137090B (en) 1986-07-09
ES8601691A1 (es) 1985-11-16
IL71363A0 (en) 1984-06-29
CH660304A5 (de) 1987-04-15
PT78312A (en) 1984-04-01
BE899277A (fr) 1984-10-01
ES8503946A1 (es) 1985-04-16
IT1173762B (it) 1987-06-24
FR2543436B1 (fr) 1988-12-16
AU2623584A (en) 1984-10-04
AU564979B2 (en) 1987-09-03
ES539275A0 (es) 1985-11-16
GB8408066D0 (en) 1984-05-10
DE3311700A1 (de) 1984-10-04
IT8420304A0 (it) 1984-03-29
ZA842336B (en) 1984-11-28
ES8601690A1 (es) 1985-11-16
CA1212328A (en) 1986-10-07
SE8401747L (sv) 1984-10-01
LU85272A1 (de) 1984-11-14
SE8401747D0 (sv) 1984-03-29
GB2137090A (en) 1984-10-03
PT78312B (en) 1986-06-02
FR2543436A1 (fr) 1984-10-05
KR840008283A (ko) 1984-12-14
PH20964A (en) 1987-06-10
ES530845A0 (es) 1985-04-16

Similar Documents

Publication Publication Date Title
ES533097A0 (es) Un procedimiento para la preparacion de nuevos derivados del amino-metil-oxooxazolidinil-benzeno.
ES495377A0 (es) Un procedimiento para la preparacion de un producto moldea- do.
AR226940A1 (es) Procedimiento para la preparacion de polimeros de silazano y los productos resultantes
MX9102763A (es) Proceso para la preparacion de productos vegetales deshidratados y productos resultantes.
ES522447A0 (es) Procedimiento para la preparacion de 1,4-diceto-pirrollo-3,4-c-pirroles
MX163732B (es) Procedimiento para preparar un producto de fibras dieteticas
AR227814A1 (es) Procedimiento para la preparacion de un producto para evitar la caida del cabello y para fomentar su crecimiento
MX9203501A (es) Procedimiento para la obtencion de nuevos derivados de omega-ciano-1-,omega-difenil-aza-alcano y productos resultantes.
MX14411A (es) Procedimiento para producir 1,2-dioxetanos e intermediarios de los mismos y producto obtenido.
AR240791A1 (es) Procedimiento para la produccion de etileno y propileno.
MX158194A (es) Procedimiento para la preparacion del sesquihidrato de un derivado de naftiridina
ES524139A0 (es) Procedimiento para preparar productos antiespasmos.
ES544290A0 (es) Un procedimiento para la preparacion de derivados del indano
MX5918A (es) Procedimiento para preparar nicotinonitrilos y producto obtenido.
ES522642A0 (es) Procedimiento para la preparacion de un producto lacteo acidi-ficado.
ES520866A0 (es) Un procedimiento para la preparacion del complejo a41030.
ES527985A0 (es) Procedimiento para la produccion de derivados de 1-fluoro-1-ariloxi-3-azolilmetil-2-alcanol.
ES534924A0 (es) Procedimiento para la obtencion de monoeteres alifaticos del 2,2-dimetilpropan-1,3-diol
ES494546A0 (es) Un procedimiento para la preparacion de derivados del pirrol
ES539274A0 (es) Un procedimiento para la obtencion de preparados del bifanazol con elevada liberacion del producto actuvo
ES511577A0 (es) Procedimiento para la preparacion del heteropolisacarido s-198.
ES524897A0 (es) Procedimiento para la preparacion de nuevos productos antihelminticos
ES550012A0 (es) Un procedimiento para la preparacion del plasmido pcz101
MX159452A (es) Procedimiento para la preparacion del 8-metoxi-4,8-dimetil-1-(4-isopropilfenil)-no-nano
ES499081A0 (es) Un procedimiento para la preparacion de un derivado del aci-do cefalosporanico

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050723